Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 26, 2009 - Issue 7
Submit an article Journal homepage
69
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Preliminary in vivo studies of a new lecithin-based formulation of paclitaxel

Malgorzata Sznitowska Department of Pharmaceutical Technology, Medical University of Gdansk, PolandCorrespondence[email protected]
,
Malgorzata Bodnar Department of Pharmaceutical Technology, Medical University of Gdansk, Poland
,
Jacek Petrusewicz Department of Pharmacology, Medical University of Gdansk, Poland
,
Helena Janik Polymer Technology and Department, Gdansk University of Technology, Poland
&
Ewa Anna Dabrowska Department of Pharmaceutical Technology, Medical University of Gdansk, Poland
Pages 588-592 | Received 18 Oct 2008, Accepted 24 Oct 2008, Published online: 05 Nov 2009

References

  • FDA Professional Drug Information, Paclitaxel official information. Available online at: www.drugs.com/pro
  • Hennenfent KL, Govindan R. Novel formulations of taxanes: A review. Old wine in a new bottle?. Ann Oncol 2006; 17: 735–749
  • Janicki S, Sznitowska M, Karas W, Mroczek Z, Tyrala A, Czarnecka I. Method for the production of a stable pharmaceutical form of paclitaxel. Eur Patent 1363892B1 2006
  • Koster VS, Kuks PFM, Lange R, Talsma H. Particle size in parenteral fat emulsions, what are the true limitations?. Int J Pharm 1996; 134: 235–238
  • Lunn G, Schmuff N. HPLC methods for pharmaceutical analysis. John Wiley & Sons, New York 1997
  • Sznitowska M, Dabrowska EA, Janicki S. Solubilizing potential of submicron emulsions and aqueous dispersions of lecithin. Int J Pharm 2002; 246: 203–206
  • Sznitowska M, Klunder M, Placzek M. Paclitaxel solubility in aqueous dispersions and mixed micellar solutions of lecithin. Chem Pharm Bull 2008; 56: 70–74
  • van den Bongard HJGD, Mathot RAA, van Tellingen O, Schellens JHM, Beijnen JH. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling. Cancer Chemother Pharmacol 2002; 50: 6–24

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.